Immune-related intestinal pseudo-obstruction associated with nivolumab treatment in a lung cancer patient

Immune checkpoint inhibition therapy using targeted monoclonal antibodies is a new therapeutic approach with significant survival benefit for patients with several cancer types. However, their use can be associated with unique immune-related adverse effects as a consequence of impaired self-toleranc...

Ausführliche Beschreibung